Acute hydrated non-compressive nucleus pulposus extrusion: what do we know so far? [PDF]
BELTRAN +11 more
core +2 more sources
Periostin as a diagnostic marker and therapeutic target for intervertebral disc degeneration. [PDF]
Yuan Y, Xu M, Qin T, Sun H, Sun J.
europepmc +1 more source
Epigenetic crossroads in intervertebral disc degeneration: Unlocking novel therapeutic avenues (Review). [PDF]
Hou Y, Liu L, Guo Y, Shi J.
europepmc +1 more source
HACE1 alleviates intervertebral disc degeneration by inhibiting ferroptosis in nucleus pulposus cells. [PDF]
Xia J +11 more
europepmc +1 more source
Dasatinib and quercetin senolytic treatment delays early onset intervertebral disc degeneration in SM/J mice. [PDF]
Novais EJ +5 more
europepmc +1 more source
Apoptosis in Temporomandibular Joint Disc with Internal Derangement Involves Mitochondrial-dependent Pathways. An \u3cem\u3ein vivo\u3c/em\u3e Study [PDF]
Almeida, Luis Eduardo +6 more
core +1 more source
S100A12 as a Shared Inflammatory Driver of Intervertebral Disc Degeneration and Osteoporosis: A Mendelian Randomization and Experimental Study. [PDF]
Wang Z, Chen B, Liu Z, Zhang Y, Han L.
europepmc +1 more source
Multi-omics Mendelian randomization prioritizes BMP6 as a candidate therapeutic target in intervertebral disc degeneration. [PDF]
Kan S +7 more
europepmc +1 more source
Immunometabolism: A Novel Therapeutic Target and Its Pharmacological Modulation for Intervertebral Disc Degeneration. [PDF]
Cheng M +5 more
europepmc +1 more source
Kallikrein-kinin system as a potential target for the treatment of intervertebral disc degeneration. [PDF]
Lu T +9 more
europepmc +1 more source

